Diabetes programme keeps Ears to the ground with new reporting platform


Diabetes programme keeps Ears to the ground with new reporting platform

Antony Savvas

Gloucestershire Hospitals NHS Trust is streamlining its national diabetes reporting programme with a bespoke system from Quicksilva.

The English National Screening Programme for Diabetic Retinopathy (ENSPDR), run by Gloucestershire Hospitals NHS Foundation Trust, is to go live later this year with a bespoke application called Ears.

Built by Quicksilva Software Solutions, Ears will streamline the Diabetic Retinopathy Screening Programme reporting process for Local Screening Programmes (LSPs) across England.

About 100 LSPs submit annual reports to the ENSPDR to help provide indicators of performance, so enabling review of risk, service delivery and improvement.

This process is currently very time intensive as reports are submitted manually in varying formats, and the ENSPDR also has manual processes for monitoring, recording, collating and analysing the information.

Ears will streamline and automate the reporting process allowing LSPs to submit their report in one of two ways - via a web interface or by uploading an HL7v3 message with the support of the screening software providers.

Fionna O'Leary, ENSPDR national programme manager, said, "Ears will provide us with the necessary level of automated co-ordination to streamline the yearly reporting process, enabling data to be more easily collated and analysed.

"It offers a more flexible reporting model for the LSPs and should enable programmes to get earlier automated feedback on performance."

Email Alerts

Register now to receive ComputerWeekly.com IT-related news, guides and more, delivered to your inbox.
By submitting your personal information, you agree to receive emails regarding relevant products and special offers from TechTarget and its partners. You also agree that your personal information may be transferred and processed in the United States, and that you have read and agree to the Terms of Use and the Privacy Policy.

COMMENTS powered by Disqus  //  Commenting policy